{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:43Z","timestamp":1794047443044,"version":"4.8.0"},"reference-count":11,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.283461","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T03:44:52Z","timestamp":1689824692000},"page":"19-20","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the role of viral hepatitis in plasma cell disorders"],"prefix":"10.3324","volume":"109","author":[{"given":"Elizabeth","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"55636","doi-asserted-by":"crossref","unstructured":"Hermouet S, Corre I, Gassin M, Bigot-Corbel E, Sutton CA, Casey JW. Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia. N Engl J Med. 2003; 348(2):178-179.","DOI":"10.1056\/NEJM200301093480219"},{"key":"55637","doi-asserted-by":"crossref","unstructured":"Bigot-Corbel E, Gassin M, Corre I, Le Carrer D, Delaroche O, Hermouet S. Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell malignancy. Blood. 2008; 112(10):4357-4358.","DOI":"10.1182\/blood-2008-07-167569"},{"key":"55638","doi-asserted-by":"crossref","unstructured":"McShane CM, Murray LJ, Engels EA, Landgren O, Anderson LA. Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study. Int J Cancer. 2014; 134(7):1734-1740.","DOI":"10.1002\/ijc.28479"},{"key":"55639","doi-asserted-by":"crossref","unstructured":"Li Y, Li Y, Zhang L, Li W. Hepatitis C virus infection and risk of multiple myeloma: evidence from a meta-analysis based on 17 case-control studies. J Viral Hepat. 2017; 24(12):1151-1159.","DOI":"10.1111\/jvh.12742"},{"key":"55640","doi-asserted-by":"crossref","unstructured":"Bosseboeuf A, Feron D, Tallet A. Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens. JCI Insight. 2017; 2(19):e95367.","DOI":"10.1172\/jci.insight.95367"},{"key":"55641","doi-asserted-by":"crossref","unstructured":"Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV. Clonal immunoglobulin against lysolipids in the origin of myeloma. N Engl J Med. 2016; 374(6):555-561.","DOI":"10.1056\/NEJMoa1508808"},{"key":"55642","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia A, Mennesson N, Hernandez-Ibarburu G. Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses. Haematologica. 2024; 109(1):272-282.","DOI":"10.3324\/haematol.2023.283096"},{"key":"55643","doi-asserted-by":"crossref","unstructured":"Zignego AL, Giannini C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol. 2007; 13(17):2467-2478.","DOI":"10.3748\/wjg.v13.i17.2467"},{"key":"55644","doi-asserted-by":"crossref","unstructured":"Teng CJ, Liu HT, Liu C Y. Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes. Clinics (Sao Paulo). 2011; 66(12):2055-2061.","DOI":"10.1590\/S1807-59322011001200010"},{"key":"55645","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia A, Linares M, Morales ML. Efficacy of antiviral treatment in hepatitis C virus (HCV)-driven monoclonal gammopathies including myeloma. Front Immunol. 2021; 12:797209.","DOI":"10.3389\/fimmu.2021.797209"},{"key":"55646","doi-asserted-by":"crossref","unstructured":"Becker N, Schnitzler P, Boffetta P. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol. 2012; 138(12):1993-2001.","DOI":"10.1007\/s00432-012-1279-y"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283461\/75835","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283461\/76408","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11175\/75835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:29Z","timestamp":1794045869000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283461","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}